Shimizu M, Akiyama S, Ito K, Kasai Y, Takagi H, Kito M, Ohishi N, Yagi K
Department of Surgery, Nagoya University School of Medicine, Japan.
Biochem Mol Biol Int. 1998 May;44(6):1235-43. doi: 10.1080/15216549800202332.
When cultured cells of human colon cancer cell line SW480 were transfected with human interferon-beta (hIFN-beta) gene by means of cationic multilamellar liposomes, the endogenously produced hIFN-beta exhibited a remarkable anti-proliferative effect on the cells, which was more effective than that of exogenously added hIFN-beta. This effect lasted for several days, and was blocked completely by the addition of sufficient amounts of anti-hIFN-beta antibody. From experiments using a transwell plate and an infusion pump, we found that endogenously produced hIFN-beta acted effectively on the cells around the transfectants and that the growth-inhibitory effect was totally retained upon continuous dilution of the medium. These data indicate that hIFN-beta expressed endogenously by transfer of its gene acted on these cancer cells mainly in a paracrine manner. Although the transfection with hIFN-gamma gene also revealed a definite growth-inhibitory effect on the same tumor cells, the extent was less than that of hIFN-beta gene.
当通过阳离子多层脂质体将人干扰素-β(hIFN-β)基因转染到人结肠癌细胞系SW480的培养细胞时,内源性产生的hIFN-β对这些细胞表现出显著的抗增殖作用,这比外源性添加的hIFN-β更有效。这种作用持续了几天,并通过添加足量的抗hIFN-β抗体而被完全阻断。通过使用Transwell板和输液泵进行的实验,我们发现内源性产生的hIFN-β对转染细胞周围的细胞有有效作用,并且在培养基连续稀释时生长抑制作用完全保留。这些数据表明,通过其基因转移内源性表达的hIFN-β主要以旁分泌方式作用于这些癌细胞。虽然用hIFN-γ基因转染也显示出对相同肿瘤细胞有一定的生长抑制作用,但其程度小于hIFN-β基因。